Pharma BD Deal Intelligence

Laboratory Corporation of America Holdings / Genzyme Genetics (business unit)

2010 · Asset Purchase · $925M · Complete

Announcement Sentiment

Positive

LabCorp agreed to acquire Genzyme's Genetics business for $925M cash. 2009 revenue ~$371M with 9 testing labs and ~1,900 employees. Closed December 1, 2010.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Financial impact

Accretive

Assessment window: 15yr post-close.

Key facts

Announced Sep 13, 2010
Closed Dec 01, 2010
Deal value $925M
Deal type Asset Purchase
Therapeutic area Genetic testing/diagnostics
Indications Genetic testing/diagnostics
Key assets Reproductive and oncology genetic testing services
Mechanism Specialty diagnostics laboratory services

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals